25-MRCO-P-298 FAR 8 STA R Max Coagulation_Redacted.pdf

This is a Justification Review Document for a FAR Part 8 Limited Sources Justification for the Madigan Army Medical Center (MAMC), Department of Pathology. The document seeks approval to award a non-competitive, four-year firm fixed price contract to Diagnostica Stago Inc. for coagulation instruments, including reagents, consumables, and services for the Core Laboratory. The requirement is for two coagulation instruments connected to the existing government-owned Roche Diagnostics Cobas 8100 Total Laboratory Automation (TLA) system to monitor and diagnose blood clotting disorders.

The contract will be for a four-year period from 1 October 2025 through 30 September 2029, with a base period and three option years. Diagnostica Stago Inc. is the exclusive provider of STA R Max and Compact Max coagulation instruments that can integrate with the Cobas 8100 TLA system manufactured by Roche. The total estimated contract value is redacted, and the procurement method is sole source. A sources sought notice was posted on SAM.gov on 13 June 2025, but no alternative sources were identified. The contracting activity will continue to research other options and conduct market research to determine if alternate sources become available in the future.